EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY 4.0

Epidemiology and clinical outcomes of monomicrobial carbapenem-resistant Enterobacteriaceae (CRE) from a metropolitan area of Kerala, India

Sanjeev K Singh, Sangita Sudhir, Vidya Menon, Anup R Warrier, Arya R V, Fabia Edathadathil, Dipu T Sathyapalan, Sivaprasad Ps, Sabu Thomas

The Journal of Infection in Developing Countries · 2025

DOI: 10.3855/jidc.18777 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Journal of Infection in Developing Countries, 2025. Verfasst von Sanjeev K Singh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, India -682041. Hauptthemen laut MEDLINE: Carbapenem-Resistant Enterobacteriaceae, Enterobacteriaceae Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The emergence of Carbapenem-resistant Enterobacteriaceae (CRE) is a major public health threat in India posing challenges in infection management. Our study aims to address the regional incidence of monomicrobial CRE in a metropolitan area of Kerala and characterize prescriptions in relation to clinical management. Methodology: The multicentre, prospective observational study was conducted in secondary and tertiary care centres jointly following public-private partnership model in Ernakulam district of Kerala, India from October 2018 to October 2019.

Results

The overall incidence of monomicrobial CRE-positive cases from the study hospital network was found to be 0.855 per 1000 patient-days. Among the available data in the cohort, 77 % (312/405) were observed to attain clinical cure and in-hospital all-cause mortality was at 20% (83/410). The proportion of patients with clinical cure to treatment was found to be significantly higher than clinical failure among patients with urinary tract infections (p < 0.001, OR 2.88, 95% CI 1.73 – 4.79) and pneumonia (p < 0.001, OR 0.36, 95% CI 0.21 - 0.6) at 87% and 61% respectively in comparison to other infections. The prevalence of colistin resistance among the total number of patients recruited with isolated monomicrobial CRE was found to be at 3%.

Conclusions

Our prospective study on the regional epidemiology of monomicrobial CRE has revealed notable incidence and all-cause mortality. The antimicrobial regimens for clinical management detailed in the study and the assessment of focus of infection-based clinical cure status rates indicate the need of optimized antimicrobial therapy to improve treatment practices in CRE infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbapenem-Resistant EnterobacteriaceaeEnterobacteriaceae InfectionsAnti-Bacterial AgentsHumansIndiaProspective StudiesMaleFemaleMiddle AgedAdultIncidenceAgedYoung AdultCarbapenemsAdolescentUrinary Tract Infections

Stichwörter der Autor:innen

AMRCRECarbapenem-resistant Enterobacteriaceaeantimicrobial resistancecolistin resistance

Substanzen

Anti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, India -682041.
  • New York City Health and Hospitals/Lincoln, New York City, New York 10451, United States.
  • Aster Medcity, Kochi, Kerala- 682027, India.
  • Ernakulam General Hospital, Kochi, Kerala-682011, India.
  • Sabu Thomas, Rajiv Gandhi Centre for Biotechnology, Trivandrum, Kerala - 695 014, India.

Zitieren

APA

Singh, S. K., Sudhir, S., Menon, V., Warrier, A. R., V, A. R., Edathadathil, F., Sathyapalan, D. T., Ps, S., & Thomas, S. (2025). Epidemiology and clinical outcomes of monomicrobial carbapenem-resistant Enterobacteriaceae (CRE) from a metropolitan area of Kerala, India. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.18777

Vancouver

Singh SK, Sudhir S, Menon V, Warrier AR, V AR, Edathadathil F, et al. Epidemiology and clinical outcomes of monomicrobial carbapenem-resistant Enterobacteriaceae (CRE) from a metropolitan area of Kerala, India. The Journal of Infection in Developing Countries. 2025. doi:10.3855/jidc.18777

BibTeX
@article{Singh2025,
  author = {Singh, Sanjeev K and Sudhir, Sangita and Menon, Vidya and Warrier, Anup R and V, Arya R and Edathadathil, Fabia and Sathyapalan, Dipu T and Ps, Sivaprasad and Thomas, Sabu},
  title = {Epidemiology and clinical outcomes of monomicrobial carbapenem-resistant Enterobacteriaceae (CRE) from a metropolitan area of Kerala, India},
  journal = {The Journal of Infection in Developing Countries},
  year = {2025},
  doi = {10.3855/jidc.18777}
}
Kostenlos starten →